Pharma CDMOs and big picture details
Today’s pharma contract development and manufacturing organizations have to do both. CDMOs are winning over clients by not only taking on major global challenges, but also by providing expertise in their respective processes.
On the surface, we see CDMOs tackling big issues: stopping COVID-19, enabling the next generation of medicines, and slowing climate change.
This month, we highlighted four companies as “CDMOs with vision” — but it quickly became evident that vision alone did not make them successful. Behind the scenes, we saw skilled industry experts who were meticulous about the details…